Effects of Neurodynamic and Carpal Bone Mobilization in Mild-to-Moderate Carpal Tunnel Syndrome
Clinical and Morphological Effects of Neurodynamic Mobilization and Carpal Bone Mobilization Techniques in Patients With Mild-to-Moderate Carpal Tunnel Syndrome
1 other identifier
interventional
93
1 country
1
Brief Summary
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy caused by compression of the median nerve at the wrist. Conservative interventions such as splinting and manual therapy are frequently used in individuals with mild-to-moderate CTS. Neurodynamic mobilization and carpal bone mobilization aim to improve neural and soft tissue mobility; however, their comparative effects on clinical outcomes and median nerve morphology are not fully understood. This interventional, non-randomized clinical study aims to compare the clinical and ultrasonographic effects of neurodynamic mobilization plus splinting, carpal bone mobilization plus splinting, and splinting alone in patients with mild-to-moderate CTS. Ninety-three participants diagnosed with mild-to-moderate carpal tunnel syndrome based on electrodiagnostic criteria will be included. Participants will be allocated into three parallel groups without randomization. All participants will receive a neutral-position wrist splint as standard conservative care. Two intervention groups will additionally receive either neurodynamic mobilization exercises or carpal bone mobilization techniques administered by a physiotherapist for four weeks. Clinical outcomes and median nerve morphology will be evaluated at baseline and immediately after the intervention period. The primary outcome is the change in the Boston Carpal Tunnel Questionnaire score. Secondary outcomes include pain intensity, neuropathic pain, functional disability, muscle strength, pressure pain threshold, and ultrasonographic measurements of the median nerve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2026
CompletedStudy Start
First participant enrolled
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 15, 2027
January 22, 2026
January 1, 2026
1 year
January 13, 2026
January 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Boston Carpal Tunnel Questionnaire (BCTQ) Total Score
Change in Boston Carpal Tunnel Questionnaire (BCTQ) Total Score
Baseline to 4 weeks
Secondary Outcomes (7)
Visual Analog Scale (VAS)
Baseline to 4 weeks
Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)
Baseline to 4 weeks
Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH)
Baseline to 4 weeks
Grip Strength
Baseline to 4 weeks
Pinch Strength
Baseline to 4 weeks
- +2 more secondary outcomes
Study Arms (3)
neurodynamic mobs in addition splint
EXPERIMENTALMedian nerve neurodynamic mobilization exercises administered by a physiotherapist for 4 weeks in addition to night-time wrist splint use
Carpal Bone Mobilization + Splint
EXPERIMENTALCarpal bone mobilization techniques administered by a physiotherapist for 4 weeks in addition to night-time wrist splint use.
Splint only
ACTIVE COMPARATORNeutral-position wrist splint worn at night for 4 weeks.
Interventions
Median nerve neurodynamic mobilization exercises performed 5 sessions per week for 4 weeks.
Manual carpal bone mobilization techniques applied 5 sessions per week for 4 weeks.
Neutral-position wrist splint used during night-time for 4 weeks.
Eligibility Criteria
You may qualify if:
- Diagnosis of mild-to-moderate carpal tunnel syndrome confirmed by electrodiagnostic testing
- CTS symptoms for at least 3 months
- Ability to provide informed consent
You may not qualify if:
- Previous carpal tunnel surgery
- Diabetes mellitus or polyneuropathy
- Cervical radiculopathy
- Pregnancy or breastfeeding
- Central nervous system disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kutahya Health Sciences University Yoncalı Physical Therapy and Rehabilitation Hospital
Kütahya, Yoncalı, 43000, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Merve Akdeniz Leblebicier, MD
Kutahya Health Sciences University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
January 13, 2026
First Posted
January 22, 2026
Study Start
January 15, 2026
Primary Completion (Estimated)
January 15, 2027
Study Completion (Estimated)
March 15, 2027
Last Updated
January 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share